antipsychotics part ii
DESCRIPTION
This PPT is part 2 of 2 lectures given to second year pharmacy students in a pharmacology & toxicology class.TRANSCRIPT
Anti-psychotics IIBrian J. Piper, Ph.D., M.S.
February 4, 2013
Goals• Pharmacy students should be able to:
– describe the MOA and adverse effects of second generation antipsychotics
– evaluate the relative pros and cons (acute and long-term) of first and second generation antipsychotics
DSM5 Diagnosis of Schizophrenia• Two or more of the following, including 1, 2, or 3
1. Delusions2. Hallucinations3. Disorganized speech4. Grossly abnormal psychomotor behavior5. Negative symptoms
• Duration: 1 month during last 6• Social/occupational dysfunction• Exclusion: medical condition or drug
Atypical (Second Generation)• Mechanism of Action
– Dissociate more rapidly from the D2 receptor
Stahl, S. (2008). Essential Psychopharmacology, p. 369-370.
MOA of Atypical Antipsychotics• Dissociate more rapidly from the D2 receptor
– ↓ acute EPS, ↓ hyperprolactinemia
Stahl, S. (2008). Essential Psychopharmacology, p. 371.
MOA of Atypicals • Atypicals
– Dissociate more rapidly from the D2 receptor
– Block the 5-HT2A (and so many other!) receptors
Stahl, S. (2008). Essential Psychopharmacology, p. 384.
5-HT2A
• Hallucinogens = 5-HT2A agonists• Receptor Distribution: cortex
[11C]MDL100,907
Meyer et al. (2010). Neuroimage, 50(3), 984-993.
Brain Morphology & Schizophrenia
Some schizophrenia patients exhibit morphological changes in the brain like
enlargement of fluid-filled ventricles.
Adverse Effect of Atypicals I: Weight Gain
Weight Gain & OlanzapineWeight Gain Relative to Baseline (1.6 yrs)
% of Patients
> 7% 64%> 15% 32%> 25% 12%
Citrome et al. (2011). Journal of Clinical Investigation, 31(7), 455-482.
Risks with long-term AtypicalsMechanism: 5-HT2C
Mechanism: X
$515 Million
Concern• Adult monkeys received
FGA (haloperidol) or SGA (olanzapine) antipsychotics for 2 years at doses similar to schizophrenics.
• Gray matter in parietal cortex was examined.
Konopaske et al. (2007). Neuropsychopharmacology, 32, 1216-1223.
**
Do antipsychotics cause neurostructural changes?
Repeated MRI of schizophrenicsVentricular volume change (slope) by antipsychotic treatment
– most (+.39)– intermediate (+.36)– least (+.16)
Beng-Choon et al. (2011). Archives of General Psychiatry, 68(2), 128-137.
Do antipsychotics cause neurostructural changes?
Repeated MRI of schizophrenicsWhite matter change (slope) by antipsychotic treatment
– most (-.64)– intermediate (-.51)– least (+1.30)
Beng-Choon et al. (2011). Archives of General Psychiatry, 68(2), 128-137.
Practice Makes Perfect• FGA: http://
www.howjsay.com/index.php?word=perphenazine&submit=Submit
• SGA:– http://www.howjsay.com/index.php?word=ziprasidone&submit=Submit– http://www.howjsay.com/index.php?word=quetiapine&submit=Submit– http://www.howjsay.com/index.php?word=risperidone&submit=Submit
Clinical Antipsychotic Trials for Intervention Effectiveness) CATIE
• 18-month randomized, double-blind trial of FGA & SGAs in real-world (N=1,432) funded by non-industry (NIMH)
Perphenazine Olanzapine Risperidone Ziprasidone Quetiapine
Discontinuation Rate 75% 64% 74% 79% 82%Weight Change(lbs/month) -0.2 +2.0 +0.4 -0.3 +0.5
Change in Cholesterol +1.5 +9.4 -1.3 -8.2 +6.6Change in Prolactin = = ↑ = =
Lieberman et al. (2005). New England Journal of Medicine, 353(12), 1209-1223.
CATIE Findings• FGAs & SGAs showed similar efficacy with a
slight advantage for olanzapine.• Olanzapine showed a higher metabolic risk
relative to both FGA and other SGAs.
Black Box For All SGAs
Cognitive Behavioral Therapy • Antipsychotics show limited efficacy for negative symptoms & many
patients continue to exhibit hallucinations & delusions• Cognitive Behavioral Therapy is a short-term, empirically based
psychotherapy developed by Aaron “Tim” Beck (left) that is used with antipsychotics.
Rector & Beck (2012). J Nervous & Mental Disease, 200(10), 832-839.
1921 -
Onset Age
• Males: early 20s• Females: late 20s
Schizophrenia in Children
• More frequently recognized• Example (0 to 3 min):
http://www.youtube.com/watch?v=UTUMt05_nCI
:
Summary
• SGAs produce less acute EPS than FGA but also cause diabetes.
• No clear consensus exists in the choice between FGA and SGA.
• Using agents at above recommended doses or combining drugs are common clinically but are not well studied.
Receptor/Adverse EffectX: diabetesM1: sedationH1: sedation, appetiteα1: sedation5-HT2C: appetite
Stahl, S. (2008). Essential Psychopharmacology, p. 384.
Self-Test #1• _________ were the top selling drugs in 2009.
– A) antipsychotics– B) oncology agents– C) antidiabetics– D) respiratory agents– E) HIV antivirals
http://www.nytimes.com/2010/10/03/business/03psych.html?_r=4&hp=&pagewanted=all&
http://survivingantidepressants.org/index.php?/topic/2963-the-top-prescription-drugs-of-2011/
Self-Test #2
• If a family member were diagnosed with schizophrenia, what agent would you prefer they receive and why? Would this differ based on age or health?